Showing results (401-410 of 510) with videos related to

Sort By:
Pageof 51
The New England Journal of Medicine|November 25, 2017
A Controlled Trial of Erenumab for Episodic MigrainePeter J Goadsby, Uwe Reuter, Yngve Hallström, et al.
Neurology|November 7, 2019
Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO StudyRichard B Lipton, Kristina M Fanning, Dawn C Buse, et al.
Journal of Medical Economics|April 15, 2020
Economic evaluations in migraine: systematic literature review and a novel approachRonan Mahon, Jasper Huels, Victoria Hacking, et al.
Neurology|August 25, 2017
Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label studyMessoud Ashina, David Dodick, Peter J Goadsby, et al.
Headache|February 28, 2009
Defining refractory migraine: results of the RHSIS Survey of American Headache Society membersElliott A Schulman, B Lee Peterlin, Alvin E Lake, et al.
The Journal of Headache and Pain|April 2, 2021
21st century headache: mapping new territoryPeter J Goadsby, Michel Lantéri-Minet, Martin C Michel, et al.
The Lancet. Neurology|February 17, 2016
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trialHong Sun, David W Dodick, Stephen Silberstein, et al.
Brain Sciences|October 28, 2023
Mental Imagery in Dreams of Congenitally Blind PeopleJungwoo Kang, Rita Bertani, Kausar Raheel, et al.
Pageof 51